Chronic fatigue syndrome (CFS) is known as a multi-systemic and complex illness, which
induces fatigue and long-term disability in educational, occupational, social, or personal …

Chronic fatigue syndrome/myalgic encephalomyelitis (CFS) is a complex, multisystem
disease that is characterized by long-term fatigue, exhaustion, disabilities, pain …

Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) is a poorly understood
seriously debilitating disorder in which disabling fatigue is an universal symptom in …

The antiviral and antiproliferative effects of interferons are mediated in part by the 2′-5′
oligoadenylate–RNase L RNA decay pathway. RNase L is an endoribonuclease that …

ABSTRACT NIJS, J., M. MEEUS, NR MCGREGOR, R. MEEUSEN, G. DE SCHUTTER, E.
VAN HOOF, and K. DE MEIRLEIR. Chronic Fatigue Syndrome: Exercise Performance …

Protein carbonyl levels, a measure of protein oxidation, were found to be significantly
elevated (p< 0.0005) in the sera of chronic fatigue syndrome (CFS) patients vs. controls. In …

A 37-kDa binding polypeptide accumulates in peripheral blood mononuclear cell (PBMC)
extracts from chronic fatigue syndrome (CFS) patients and is being considered as a potential …

This paper provides an overview of the evidence addressing the impairments of the 2'-
5'oligoadenylate (2-5 A) synthetase/RNase L pathway in Chronic Fatigue Syndrome (CFS) …

This study examined possible interactions between immunological abnormalities and
symptoms in CFS. Sixteen CFS patients filled in a battery of questionnaires, evaluating daily …

Interferons (IFNs) inhibit the growth of many different cell types by altering the expression of
specific genes. IFNs activities are partly mediated by the 2′-5′ oligoadenylates-RNase L …